Wilfredo Hernandez Rivera's Discussions
Started May 24, 2011
Prosensa is currently conducting a clinical study to investigate the effect of PRO044 in boys with Duchenne muscular dystrophy, who have a dystrophin gene mutation amenable to an exon 44 skip.…Continue
Started this discussion. Last reply by arnold May 5, 2011.
A new drug for the muscle-wasting disease Duchenne muscular dystrophy has shown significant benefits in mice, opening the door for clinical trials…Continue
Tags: C1100, SMT
Started Nov 4, 2010
Results from the recent AVI-4658 study have been positive so far and are now awaiting further analysis in America by the sponsor AVI BioPharma. Two families that have participated in the trial in the…Continue